View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
May 17, 2021

Medical Devices industry venture financing deals total $391.2m in Europe in Q1 2021

Led by $30m venture financing of Genomics, total medical devices industry venture financing deals worth $391.2m were announced in Europe in Q1 2021, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 6.5% over the previous quarter and a drop of 0.7% when compared with the last four-quarter average of $393.93m.

Europe held an 8.50% share of the global medical devices industry venture financing deal value that totalled $4.6bn in Q1 2021. With a 3.56% share and deals worth $163.81m, France was the top country in Europe’s venture financing deal value across medical devices industry.

In terms of deal activity, Europe recorded 46 deals during Q1 2021, marking a decrease of 9.80% over the previous quarter and a drop of 13.21% over the last four-quarter average. The UK recorded 15 deals during the month.

Europe medical devices industry venture financing deals in Q1 2021: Top deals

The top five venture financing deals accounted for 34.5% of the overall value during Q1 2021.

The combined value of the top five medical devices venture financing deals stood at $134.98m, against the overall value of $391.2m recorded for the quarter.

The top five medical devices deals of Q1 2021 tracked by GlobalData were:

1) Foresite Capital Management, F-Prime, Lansdowne Partners and Oxford Sciences Innovation’s $30m venture financing of Genomics

2) The $30m venture financing of Menwell by Cherry Ventures, Felix Capital Partners, Sonoma Brands and Waldencast

3) Gilde Healthcare Partners and Groupe Pasteur Mutualite’s $28.21m venture financing of Volta Medical

4) The $25m venture financing of Neurent Medical by Atlantic Bridge Capital, Fountain Healthcare Partners and LSP HEF 2

5) Andera Partners, Asabys Partners, Caixa Capital Risc SGEIC, Center for the Development of Industrial Technology, Innogest Capital II and VI Partners’ venture financing of Medlumics for $21.77m.

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network